BKV Corporation (NYSE:BKV) Receives $28.17 Average Price Target from Brokerages

Shares of BKV Corporation (NYSE:BKV) have received an average recommendation of “Moderate Buy” from the seven research firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating and six have given a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $28.1667.

A number of research analysts have weighed in on the company. Mizuho upped their target price on BKV from $30.00 to $33.00 and gave the stock an “outperform” rating in a report on Thursday. Weiss Ratings reiterated a “sell (d-)” rating on shares of BKV in a report on Wednesday, October 8th. Finally, Barclays upped their target price on BKV from $29.00 to $30.00 and gave the stock an “overweight” rating in a report on Monday, July 7th.

BKV Stock Up 4.0%

Shares of NYSE:BKV opened at $23.64 on Friday. BKV has a 1 year low of $15.00 and a 1 year high of $26.78. The company has a market cap of $2.00 billion, a PE ratio of -118.21 and a beta of 1.70. The company has a debt-to-equity ratio of 0.13, a current ratio of 0.56 and a quick ratio of 0.52. The stock’s 50-day moving average is $22.25 and its 200 day moving average is $21.67.

BKV (NYSE:BKV) last posted its earnings results on Tuesday, August 12th. The company reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.15 by $0.24. BKV had a positive return on equity of 3.21% and a negative net margin of 2.69%.The firm had revenue of $322.04 million for the quarter, compared to the consensus estimate of $224.05 million. Sell-side analysts anticipate that BKV will post -1.82 EPS for the current year.

Insider Buying and Selling at BKV

In related news, insider Lindsay B. Larrick sold 15,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $23.20, for a total value of $348,000.00. Following the sale, the insider owned 176,341 shares in the company, valued at $4,091,111.20. This represents a 7.84% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 4.11% of the company’s stock.

Institutional Trading of BKV

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC grew its stake in shares of BKV by 13.9% in the 2nd quarter. Geode Capital Management LLC now owns 376,232 shares of the company’s stock worth $9,076,000 after buying an additional 45,989 shares during the last quarter. Cooper Creek Partners Management LLC purchased a new stake in shares of BKV in the 2nd quarter worth approximately $8,215,000. Quantbot Technologies LP purchased a new stake in shares of BKV in the 1st quarter worth approximately $1,605,000. Bank of New York Mellon Corp grew its stake in shares of BKV by 21.2% in the 1st quarter. Bank of New York Mellon Corp now owns 35,453 shares of the company’s stock worth $745,000 after buying an additional 6,209 shares during the last quarter. Finally, Strs Ohio purchased a new stake in shares of BKV in the 3rd quarter worth approximately $278,000.

About BKV

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.